Diagnostic and Prognostic Applications of PET/CT in Small-cell Lung Cancer
YUKINORI OKADA
TATSUHIKO ZAMA
TOMOHIRO ITONAGA
RYUJI MIKAMI
MITSURU OKUBO
SHINJI SUGAHARA
SHIHO WADA
TSUBASA KAWAMOTO
YUI MABUCHI
MASUMI KAWAGUCHI
MASANORI ISHIDA
MOTOKI NAKAI
KOICHIRO ABE
MANA YOSHIMURA
 and 
KAZUHIRO SAITO
Cancer Diagnosis & Prognosis Jul-Aug; 6(4): 608-618 DOI: 10.21873/cdp.10561

Impact of Local Treatment of the Primary Tumor on Overall Survival in De Novo Metastatic Breast Cancer: A Systematic Review and Meta-analysis
LUISANA SISCA
MARIAM GRAZIA POLITO
MICHELE IULIANI
GIUSEPPE TONINI
 and 
FRANCESCO PANTANO
Cancer Diagnosis & Prognosis Jul-Aug; 6(4): 619-629 DOI: 10.21873/cdp.10562

Lipid Profiles in Breast Cancer: Clinical Associations and Biological Insights
ANASTASIA NIKOLAKOPOULOU
KALLIOPI STAVRATI
KONSTANTINOS NASTOS
DIMITRIOS PAPACONSTANTINOU
VASILIKI MICHALAKI
GEORGIOS KOUTROULIS
NIKOLAOS DAFNIOS
IOANNIS PAPAKONSTANTINOU
 and 
CHRISTOS PAPADIMITRIOU
Cancer Diagnosis & Prognosis Jul-Aug; 6(4): 630-638 DOI: 10.21873/cdp.10563

CDKN2A mRNA Over-expression Is Associated With CD8+ T Cell Exclusion and IDO1-Mediated Adaptive Immune Resistance in Gastric Adenocarcinoma
STEVEN LEHRER
 and 
PETER RHEINSTEIN
Cancer Diagnosis & Prognosis Jul-Aug; 6(4): 639-648 DOI: 10.21873/cdp.10564

HER2 Expression and Nuclear Localization in Clear Cell Renal Cell Carcinoma: Implications for Prognosis and Therapeutic Targeting
MARÍA ALICIA CORTÉS
HÉCTOR MARCELO MARÍN
NADIA BARBÁS
ROSALIA CORDO-RUSO
LUCIA ROTT
GUSTAVO EMILIO GIUSIANO
 and 
LUIS ANTONIO MERINO
Cancer Diagnosis & Prognosis Jul-Aug; 6(4): 649-659 DOI: 10.21873/cdp.10565

Optimized Prostate Cancer Stage Classification Using XGBoost Based on Racial miRNA Expression
JHENO SYECHLO
DAVID AGUSTRIAWAN
VINCENT KURNIAWAN
ADITHAMA MULIA
EZRA BERNARDUS WIJAYA
RIZKY NURDIANSYAH
DINAR AJENG KRISTIYANTI
 and 
AJIE KUSUMA WARDHANA
Cancer Diagnosis & Prognosis Jul-Aug; 6(4): 660-673 DOI: 10.21873/cdp.10566

Living-donor Kidney Transplantation After Resection of Mixed Epithelial and Stromal Tumor: A Positive Outcome Despite Not Observing the Recommended Waiting Period
KEISUKE NAKAI
YUKI KOBARI
MAYU HAKOZAKI
TAKASHI IKEDA
AYAKA SAITO
DAIGO OKADA
ARISA WADA
HIRONORI FUKUDA
TAKAYUKI NAKAYAMA
KOHEI UNAGAMI
KAZUHIKO YOSHIDA
TOSHIHITO HIRAI
TOMOKAZU SHIMIZU
JUNPEI IIZUKA
HIDEKI ISHIDA
YOJI NAGASHIMA
 and 
TOSHIO TAKAGI
Cancer Diagnosis & Prognosis Jul-Aug; 6(4): 674-681 DOI: 10.21873/cdp.10567

Baseline Neutrophil-to-Lymphocyte Ratio Predicts Overall Survival in PD-L1-positive Advanced Triple-negative Breast Cancer With Immune-checkpoint-inhibitor Treatment
AKIHIRO FUJIMOTO
YUKI ICHINOSE
KAZUO MATSUURA
EMI MIKAMI
WAKAKO INOHANA
TAEKO KUROSAWA
AYAKO NAKAME
AYAKA SAKAKIBARA
ASAMI NUKUI
AYA ASANO
HIROKO SHIMADA
HIDEKI YOKOGAWA
MASAHIRO OHARA
HIROSHI ISHIGURO
TAKAHIRO HASEBE
AKIHIKO OSAKI
 and 
TOSHIAKI SAEKI
Cancer Diagnosis & Prognosis Jul-Aug; 6(4): 682-691 DOI: 10.21873/cdp.10568

Prognostic Impact of Skeletal Muscle Radiodensity in Advanced Urothelial Carcinoma Undergoing Avelumab Maintenance Therapy
NOBUHIKO SHIMIZU
TAKU NAIKI
YOSUKE SUGIYAMA
AYA NAIKI-ITO
TAKASHI NAGAI
TOSHIKI ETANI
HIROKO SUZUKI
YOHEI TSUBOUCHI
TOSHIHARU MORIKAWA
MASAKAZU GONDA
MARIA AOKI
DAIKI ISHIKAWA
RYOSUKE ANDO
 and 
TAKAHIRO YASUI
Cancer Diagnosis & Prognosis Jul-Aug; 6(4): 692-702 DOI: 10.21873/cdp.10569

Prognosis Using Modified Albumin–Bilirubin Grade in Resected Biliary Tract Cancer: A Multicenter Propensity Score–matched Analysis
TORU TAKAHASHI
HIROAKI YANAGIMOTO
MASAYUKI AKITA
DAISUKE TSUGAWA
MICHIHIKO YOSHIDA
YASUHIRO UEDA
TARO OKAZAKI
KIMIHIKO UENO
HAYATO MIYAZAKI
IZURU OTSUBO
SHOHEI KOMATSU
 and 
TAKUMI FUKUMOTO
Cancer Diagnosis & Prognosis Jul-Aug; 6(4): 703-714 DOI: 10.21873/cdp.10570

Comparison of Automated Urinalysis Parameter Atyp.C and Urine Cytology for Detecting Bladder Carcinoma In Situ
RYU SHIGEHISA
SATOSHI FUKATA
KEISUKE SUGIMOTO
SHIORI MIYAZAKI
SHINJI TOKUHIRO
ANANTYA PUSTIMBARA
CHIAKI KAWADA
RIE YOSHIMURA
KEISUKE MIZUTANI
DAIGO TAKEMORI
YUHEI SHIBA
SHINKURO YAMAMOTO
HIROTO OSAKABE
TOMOYA NAO
TSUTOMU SHIMAMOTO
HIDEO FUKUHARA
NOBUTAKA SHIMIZU
SHINGO ASHIDA
 and 
KEIJI INOUE
Cancer Diagnosis & Prognosis Jul-Aug; 6(4): 715-722 DOI: 10.21873/cdp.10571

Tumor Marker Index Based on CEA and CA19-9 as a Prognostic Biomarker in Resectable Colon Cancer
TATSUFUMI KOSUGE
JUNICHI MAZAKI
KENTA KASAHARA
HIROAKI OSAKABE
HIROSHI KUWABARA
KENICHI IWASAKI
JUNYA OGUMA
HIROYUKI KOGA
AKISHIGE KANAZAWA
 and 
YUICHI NAGAKAWA
Cancer Diagnosis & Prognosis Jul-Aug; 6(4): 723-728 DOI: 10.21873/cdp.10572

The Clinical Impact of Prognostic Nutritional Index at Recurrence of Pancreatic Cancer
TERUHISA SAKAMOTO
KENTARO UEHIRA
JUN YOSHIDA
MIKIYA KISHINO
MASAKI MORIMOTO
YUKI MURAKAMI
KOZO MIYATANI
YUJI SHISHIDO
KYOICHI KIHARA
TOMOYUKI MATSUNAGA
MANABU YAMAMOTO
 and 
YOSHIYUKI FUJIWARA
Cancer Diagnosis & Prognosis Jul-Aug; 6(4): 729-736 DOI: 10.21873/cdp.10573

The Impact of Comprehensive Panel NGS Testing and Cascade Family Screening on Early Diagnosis of Prostate Cancer and MINAS (ATM+MITF) Management
İREM BİLGETEKİN
TAHA BAHSİ
YUSUF BAHAP
MEHMET ALİ ERGÜN
 and 
İBRAHİM GÜLLÜ
Cancer Diagnosis & Prognosis Jul-Aug; 6(4): 737-744 DOI: 10.21873/cdp.10574

Possible Sarcopenia and Functional Decline After Colorectal or Gastric Cancer Surgery
NAOHIRO FURUYA
JUNICHI ANDO
HINATA MURAKAMI
AOI HASHIMOTO
YUKI TAKANO
 and 
DAISUKE SOMA
Cancer Diagnosis & Prognosis Jul-Aug; 6(4): 745-754 DOI: 10.21873/cdp.10575

Total Bone Uptake as a Quantitative Imaging Biomarker for Prostate Cancer With Bone Metastases
SHUNSUKE WATANABE
DAISUKE MOTOYAMA
KYOHEI WATANABE
HIROMITSU WATANABE
KEITA TAMURA
 and 
TERUO INAMOTO
Cancer Diagnosis & Prognosis Jul-Aug; 6(4): 755-760 DOI: 10.21873/cdp.10576

Clinical Significance of Transjugular Liver Biopsy in Liver Dysfunction During Immune Checkpoint Inhibitor Therapy
TORU ISHIKAWA
MASAYA GOTO
RYO JIMBO
SHUN YAMAZAKI
TAKAHIRO IWASAWA
 and 
TERASU HONMA
Cancer Diagnosis & Prognosis Jul-Aug; 6(4): 761-768 DOI: 10.21873/cdp.10577

When Blood Speaks Before the Scan: The Role of ctDNA in Real-time CRC Care
NASIM SALIMIAGHDAM
EMMA LI
 and 
HONGYAN LIANG
Cancer Diagnosis & Prognosis Jul-Aug; 6(4): 769-779 DOI: 10.21873/cdp.10578

Early Initiation of Adjuvant Nivolumab After Esophagectomy Is Associated With Immune-related Liver Injury
NATSURU SUDO
YOH KAJIYAMA
KOHEI SATO
JUN YAMAMOTO
MASANORI NOBUHIRO
KAZUAKI KOBAYASHI
 and 
SHIROU KUWABARA
Cancer Diagnosis & Prognosis Jul-Aug; 6(4): 780-794 DOI: 10.21873/cdp.10579

Cancer of Unknown Primary Most Suggestive of Colorectal Origin With Microsatellite Instability-high Status and High Tumor Mutation Burden Including NTRK Fusion
HIROFUMI SATO
MASATSUGU HIRAKI
TOMONORI SHIMONISHI
YUKARI TAKASE
NATSUKO KOMIYA
CHIHO NAKASHIMA
HIROYUKI IRIE
YOSHITO AKAGI
 and 
NAOKO ARAGANE
Cancer Diagnosis & Prognosis Jul-Aug; 6(4): 795-802 DOI: 10.21873/cdp.10580